浑水摸鱼清源
Rocket Lab即便在营收激增至80亿美元且实现40%高营业利润率的极端牛市假设下,估值也仅能带来约70%的上涨空间,无法为投资者补偿发射延期与SpaceX竞争的高额下行风险。
AI-assisted summary of 【UNRIVALED INVESTING】Rocket Lab到底部了?现在能买吗? — original source. Check the original for full context.
Source published:
Key ideas
- Rocket Lab's revenue is heavily dominated by Space Systems manufacturing (~80%) rather than launch services (~20%), despite public focus on its rocket operations. (0:00)
- The company faces two major strategic crosscurrents: the maiden launch of the 13-ton Neutron rocket has been postponed to early 2027, while a proposed $8 billion acquisition of Iridium would bring high-margin satellite recurring revenue at the expense of heavy equity dilution. (0:00)
- Total backlog reached $2.3 billion in Q2, with management projecting approximately 45% (about $1 billion) will convert into recognized revenue over the next 12 months. (5:00)
- Aggressive high-case financial modeling yields only ~70% upside from a $40 billion base valuation, failing to offer the 300% to 500% asymmetric upside typically required to justify execution risks in high-growth tech equities. (11:34)
Detailed notes
## Background Published on Bilibili by channel 浑水摸鱼清源 on October 18, 2026, this video translates and analyzes commentary from Daniel of Unrivaled Investing on whether commercial aerospace firm Rocket Lab (RKLB) has bottomed out. The accompanying show notes detail Rocket Lab's position behind SpaceX, contrasting its operational Electron rocket and Space Systems cash flows with the high-stakes development of the Neutron rocket, valuation models, and operational risk factors.
## TL;DR Host Daniel analyzes Rocket Lab's steep market decline, emphasizing that satellite and space systems manufacturing—not launch services—drives approximately 80% of current revenue. The episode examines major strategic catalysts, including the delayed maiden launch of the 13-ton Neutron rocket to early 2027 and the proposed $8 billion acquisition of Iridium, alongside intense competitive pressure from SpaceX's Falcon 9 and Starship. Modeling an aggressive bull scenario where annual revenue scales to $8 billion with a 40% operating margin, Daniel demonstrates that the stock yields only ~70% upside from a $40 billion valuation base. Concluding that this modest return fails to provide the 300% to 500% upside necessary to justify high-growth tech execution risks, he challenges bulls to substantiate the math behind higher price targets.
## Atmosphere & style The presentation carries a measured, sober, and analytical tone, serving as a rigorous reality check against speculative space-industry hype. Daniel maintains an objective, disciplined delivery, balancing genuine recognition of Rocket Lab's operational milestones with unsparing scrutiny of its unit economics, cash burn, and valuation constraints. Watching the segment feels like sitting through a meticulous institutional investment committee review, methodically stripping away visionary narrative to expose the stark mathematical realities of risk-reward asymmetry.
## Bulletin - [00:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=0s) Rocket Lab's revenue is heavily dominated by Space Systems manufacturing (~80%) rather than launch services (~20%), despite public focus on its rocket operations. - [00:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=0s) The company faces two major strategic crosscurrents: the maiden launch of the 13-ton Neutron rocket has been postponed to early 2027, while a proposed $8 billion acquisition of Iridium would bring high-margin satellite recurring revenue at the expense of heavy equity dilution. - [05:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=300s) Total backlog reached $2.3 billion in Q2, with management projecting approximately 45% (about $1 billion) will convert into recognized revenue over the next 12 months. - [11:34](https://www.bilibili.com/video/BV16CJQ6YEKv?t=694s) Aggressive high-case financial modeling yields only ~70% upside from a $40 billion base valuation, failing to offer the 300% to 500% asymmetric upside typically required to justify execution risks in high-growth tech equities.
## Key takeaways - [00:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=0s) Rocket Lab experienced a steep market correction, losing roughly two-thirds of its valuation within months after previously nearing a $100 billion market capitalization. - [00:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=0s) Contrary to general perceptions, launch services (Electron and HASTE) represent only a minor slice of Rocket Lab's business, while Space Systems components and satellite manufacturing account for roughly 80% of revenue. - [00:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=0s) Ongoing lack of operational profitability magnifies share price volatility because multi-billion-dollar enterprise valuations depend heavily on unproven long-term expectations. - [00:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=0s) Testing and engineering delays pushed the maiden launch of the 13-ton medium-lift Neutron rocket from late 2026 into early 2027, creating significant market selling pressure. - [00:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=0s) The proposed $8 billion acquisition of Iridium would add roughly $900 million in annual revenue at ~60% EBITDA margins, but requires substantial equity dilution through new share issuance. - [05:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=300s) Total customer backlog expanded sequentially by 6% from $2.2 billion in Q1 to $2.3 billion in Q2, divided roughly evenly between commercial and government clients. - [05:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=300s) Management expects approximately 45% of the backlog (around $1 billion) to convert into recognized revenue over the next 12 months. - [05:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=300s) SpaceX holds a structural cost advantage per ton to orbit with Falcon 9 (23 tons to LEO) and Starship (~100 tons to LEO) relative to Neutron's 13-ton rated capacity. - [10:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=600s) The bull thesis relies on dual-sourcing mandates from defense customers and commercial avoidance of SpaceX by Starlink competitors to sustain Neutron launch demand. - [10:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=600s) Downstream constellation services, IoT demand, and satellite-based data transmission could provide a flywheel to scale top-line revenue toward $5 billion to $10 billion over a 5- to 10-year horizon. - [11:34](https://www.bilibili.com/video/BV16CJQ6YEKv?t=694s) A high-case valuation model assuming revenue scaling from $1 billion to $8 billion, a 40% operating margin, and a 30x P/E multiple implies an enterprise valuation of roughly $70 billion. - [11:34](https://www.bilibili.com/video/BV16CJQ6YEKv?t=694s) At an implied ~$40 billion baseline (incorporating potential acquisitions), the aggressive high-case outcome generates only around 70% total upside, leaving little room for execution error. - [13:25](https://www.bilibili.com/video/BV16CJQ6YEKv?t=805s) The risk-reward asymmetry is skewed negatively for investors, as technology growth stocks generally require a 300% to 500% upside potential to justify severe downside risks if targets are missed. - [13:25](https://www.bilibili.com/video/BV16CJQ6YEKv?t=805s) Bulls must justify whether their valuation framework relies on sustained P/E multiples above 50x, operating margins far exceeding 40%, or revenue scaling significantly beyond $8 billion.
## Detailed walkthrough ### [00:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=0s) Business Overview, Market Sell-Off, and the Neutron & Iridium Catalysts
Rocket Lab (ticker: RKLB) has witnessed extreme market turbulence. After once approaching nearly a $100 billion valuation, the stock experienced a severe downturn, losing roughly two-thirds of its market capitalization within a matter of just a couple of months. Host Daniel from *Unrivaled Investing* emphasizes that to understand this dramatic sell-off, investors need to look past simple preconceptions of the company. While external observers often associate Rocket Lab purely with rocket launches—such as their operational Electron rocket or the HASTE suborbital launch vehicle—launch services represent only a minor fraction of overall revenue. In reality, the vast majority of Rocket Lab's business lies in its Space Systems segment, which manufactures and operates critical hardware, complex satellites, and spacecraft components. According to data cited via an AI assistant named Flash, space systems manufacturing comprises approximately 80% of current revenues.
```mermaid flowchart TD accTitle: Rocket Lab Revenue and Strategic Initiatives Architecture accDescr: Diagram illustrating current business split and future strategic growth drivers including Neutron and the proposed Iridium deal.
subgraph Current["Current Core Business"] SS["Space Systems (~80% Revenue)<br/>Satellite Components & Manufacturing"] LS["Launch Services (~20% Revenue)<br/>Electron Rocket & HASTE Suborbital"] end
subgraph Catalysts["Strategic Next Steps & Catalysts"] N["Neutron Medium-Lift Rocket<br/>13-ton LEO Payload (Punted to early 2027)"] IR["Proposed $8B Iridium Acquisition<br/>LEO Satcom (~$900M Rev, ~60% EBITDA Margin)"] end
Current --> Catalysts ```
Despite its multi-billion-dollar market stature, Rocket Lab remains unprofitable, which inherently magnifies share price volatility. Daniel highlights this core dynamic: “Whenever you're talking about a company that's unprofitable and worth tens of billions of dollars, it means there's a lot of expectations built in.” Two pivotal strategic catalysts are shaping expectations, both of which have introduced friction:
1. **The Neutron Medium-Lift Rocket**: Designed to transport 13 tons into low Earth orbit (LEO), Neutron is aimed at constellation deployments and heavier payloads with a reusable architecture to reduce launch costs. However, testing and engineering hit snags, forcing management to punt the maiden launch from late 2026 into early 2027, which triggered intense selling pressure. 2. **The Proposed $8 Billion Iridium Acquisition**: Rocket Lab plans to purchase satellite communications giant Iridium in an $8 billion transaction scheduled to close around mid-2027. Iridium operates a constellation of roughly 66 active LEO satellites that generate predictable, high-margin subscription cash flow across voice and data networks. While Iridium brings in nearly $900 million in annual revenue alongside roughly 60% EBITDA margins and a vast proprietary spectrum portfolio, financing the deal requires substantial equity dilution through new share issuances, adding to investor anxiety.
[05:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=300s) Forward Growth Trajectory, Backlog Strength, and the SpaceX Competitive Threat
Assessing Rocket Lab's medium-to-long-term upside requires examining how its revenue pillars stack up. If the Iridium merger successfully closes, it immediately injects a $900 million recurring revenue base. Layered on top of that are potential Neutron commercial launches; scaling to roughly 20 flights annually at an estimated $50 million per launch would tack on another $1 billion annual run-rate. Combined with defense satellite contracts and proprietary subsystems, total revenue could plausibly expand to between $5 billion and $10 billion over a 5-to-10-year horizon.
Current fundamentals demonstrate clear commercial traction. Backlog climbed sequentially by about 6% from $2.2 billion in Q1 to $2.3 billion in Q2. Customer composition is split roughly evenly between commercial clients (around 50%) and government agencies. Management projects that approximately 45% of this total backlog will be realized into recognized revenue over the following 12 months, setting up roughly $1 billion in near-term forward top-line revenue.
After sharing a brief testimonial from an *Unrivaled Investing* Discord subscriber named Melvin—who shared how studying valuation principles helped him recover from a 55% portfolio draw-down and return to profitability—Daniel addresses the massive competitive shadow cast by SpaceX. Neutron is positioned to compete directly against SpaceX's Falcon 9 workhorse. While Falcon 9 delivers roughly 23 tons of payload to low Earth orbit, Neutron is rated for around 13 tons. Furthermore, SpaceX's next-generation Starship promises to deliver approximately 100 tons to orbit, drastically lowering launch costs per ton.
Daniel voices his deep structural hesitation: “The reality is SpaceX is going to have a lower cost per ton of materials that they're able to bring into space just because that they're able to ship and they've had this runway of being able to get Falcon 9 into space for longer than with Rocket Lab's Neutron, in which Neutron's expecting to have their maiden flight next year.” In contrast, Rocket Lab bulls argue that an aggressive price decline across the industry will expand the overall market: cheaper access to orbit will spur an explosion in satellite deployments, providing ample room for Rocket Lab's Space Systems and launch capacity to flourish.
- **Current Backlog Level**: Expanded from $2.2 billion in Q1 to $2.3 billion in Q2 (approx. 6% sequential growth). - **12-Month Revenue Conversion**: Management expects ~45% of the backlog (around $1 billion) to convert within a year. - **Backlog Mix**: Roughly 50% commercial clients and 50% government contracts. - **Estimated Neutron Economics**: Hypothetical cadence of 20 launches per year at $50 million each equals $1 billion in top-line potential. - **Comparative Orbital Capacities**: Starship (~100 tons payload to LEO) vs. Falcon 9 (~23 tons) vs. Neutron (~13 tons).
[10:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=600s) The Bull Thesis: Space Systems, Strategic Customer Choice, and Constellation Upside
The host highlights that space systems remain the operational core of Rocket Lab's business model, extending well beyond basic rocket launches to include satellite buses, solar arrays, and essential spacecraft components. Bulls heavily rely on this diversified foundation alongside the structural market reality that space customers inherently value choice. Even if Rocket Lab faces a unit-cost disadvantage when delivering mass to orbit or deeper into the solar system compared to SpaceX, national security and defense customers strongly prioritize having multiple independent launch providers to avoid single-point failure risks. Furthermore, commercial satellite operators that compete directly with Starlink are reluctant to hand launch contracts to SpaceX, creating natural commercial demand that protects Neutron’s prospective pricing power once commercial operations commence.
Beyond launch contracts and hardware, bulls point to a broader constellation flywheel centered on Internet of Things (IoT) demand, satellite-based data transmission, and building out proprietary satellite fleets. While operating at a much smaller scale than Starlink today, this positioning offers Rocket Lab an avenue to enter high-margin data and connectivity markets. The host acknowledges that this constellation potential presents a valid counterpoint that could support exponential top-line expansion, scaling annual revenue from a few hundred million dollars toward $1 billion in the near term, and potentially into the $5 billion to $10 billion ballpark over the long run.
As the host explains regarding customer dynamics: “National security customers value having multiple launch providers and... some of these customers currently using SpaceX are actually Starlink rivals and they may prefer an independent launch provider.”
```mermaid flowchart TD accTitle: Rocket Lab Bull Growth Drivers accDescr: Flow diagram showing how Rocket Lab leverages space systems, independent launch access, and constellation services.
subgraph Core["Core Capabilities"] A["Space Systems Hardware<br>(Satellite Buses, Solar Arrays, Components)"] B["Independent Launch<br>(Neutron & Electron)"] end
subgraph Market["Market Catalysts"] C["National Security Contracts<br>(Dual-sourcing mandates)"] D["Commercial Starlink Rivals<br>(Seeking non-SpaceX launch)"] end
subgraph Flywheel["Downstream Expansion"] E["Constellation & Data Fleets<br>(IoT demand & satellite data transmission)"] end
A --> E B --> C B --> D C --> E D --> E ```
[11:34](https://www.bilibili.com/video/BV16CJQ6YEKv?t=694s) High-Case Financial Modeling and the Valuation Squeeze
Evaluating the stock through a hypothetical high-case valuation framework reveals significant friction between operational optimism and investor returns. Modeling a scenario where the stock trades at approximately $55 per share translates into a market capitalization of roughly $40 billion (incorporating assumptions such as completed acquisitions). To test whether current pricing leaves adequate upside, the host models an aggressive operational trajectory where revenue expands from $1 billion over the coming year all the way to $8 billion.
Under this optimistic forecast, the model incorporates a 40% operating margin—an extraordinarily generous assumption given Rocket Lab's historically negative operational profitability—along with normalized tax adjustments and a rich 30x price-to-earnings (P/E) multiple. Even under these aggressive inputs, the implied enterprise valuation reaches roughly $70 billion, translating into only about 70% total upside from the hypothetical $40 billion base. The host concludes that pricing in such high growth leaves virtually no safety margin, requiring nearly every execution variable to perform flawlessly just to generate modest returns.
Evaluating the strain embedded in these assumptions, the host notes: “That just means, in my opinion, that the... assumptions that investors are looking to put into the stock are just too high.”
| High-Case Model Metric | Bull Assumption / Input | Model Output / Consequence | |:--- |:--- |:--- | | **Current Baseline Framework** | ~$55 share price | ~$40 billion market cap | | **Projected Revenue Growth** | Scaling from ~$1B to $8B | 8x top-line expansion | | **Operating Margin** | 40% operating margin | Demands massive turnaround from negative margins | | **Valuation Multiple** | 30x P/E multiple | Premium multiple maintained at scale | | **Implied Terminal Valuation** | Combined high-case parameters | ~$70 billion valuation | | **Net Expected Return** | $40B base to $70B outcome | **~70% total upside** |
[13:25](https://www.bilibili.com/video/BV16CJQ6YEKv?t=805s) Asymmetric Risk-Reward, Call to Bulls, and Conclusion
Because the high-case scenario yields only ~70% upside despite requiring hyper-growth, the host finds the risk-reward profile excessively speculative. In high-growth technology equities, an attractive bull scenario typically requires potential upside in the range of 300% to 500% to justify the severe downside risks if targets are missed. Rocket Lab's current pricing fails to provide that asymmetry, leaving investors exposed to substantial capital loss should execution stumble.
The host directly challenges Rocket Lab bulls to clarify the specific math supporting higher price targets. To generate several hundred billion dollars in enterprise value, an investor must justify either a 50x earnings multiple sustained under an assumed launch duopoly, an operational margin profile far exceeding 40%, or revenue expanding well beyond $8 billion. In closing, the host emphasizes that the analysis is designed not as dismissive skepticism, but as a disciplined, rational framework to help investors weigh astronomical expectations against realistic business fundamentals, inviting viewers to like, subscribe, and follow his personal portfolio journey at Unrivaled Investing.
Reflecting on his investment criteria and hurdle rates, the host states: “And that's frankly what I'm aiming for in the high case scenarios of saying, wait a second, what's an assumption that I think could happen? And you get that reward.”
- **Downside Asymmetry**: Modest projected upside (~70%) fails to compensate for high capital-expenditure execution risks and potential competitive pressure. - **Target Bull Hurdle**: High-case tech investing generally targets 300% to 500% upside scenarios. - **Open Questions for Bulls**: Requires clarifying whether models rely on sustained >50x P/E multiples, revenue >$8 billion, or margins significantly higher than 40%.
## Notable quotes > [00:00](https://www.bilibili.com/video/BV16CJQ6YEKv?t=0s) Whenever you're talking about a company that's unprofitable and worth tens of billions of dollars, it means there's a lot of expectations built in. — Daniel
## Mentioned Rocket Lab, SpaceX, Electron, HASTE, Neutron, Iridium, Falcon 9, Starship, Starlink, Archimedes, Daniel, Melvin, Unrivaled Investing, Flash
## 弹幕氛围 (Danmaku mood) — 1 条 由于有效弹幕仅有一条无实质意义的标点符号,整体无法体现观众的情绪基调或群体讨论氛围。弹幕反应极为单一,属于典型的中性无意义输入,推测为观众操作过程中的手滑或误触发送。
**整体情绪**:😊 正面 0% · 😐 中性 100% · 😞 负面 0%
**热议点** - **误触或手滑发送的单一标点符号** —— “】” - **未输入完整内容的残留右括号** —— “】” - **无实际交流意图的单字符弹幕** —— “】”
**代表弹幕** > 】
> 】
> 】
> 】
> 】
## Video description 【UNRIVALED INVESTING】 Rocket Lab到底部了?现在能买吗? Rocket Lab (RKLB): Bottom?
今天我们来深度聊聊美股市场中备受关注的硬科技商业航天标的——Rocket Lab(股票代码:RKLB)。近期美股航天板块经历了剧烈波动,很多投资者都在关心:当前价位到底是不是RKLB的绝佳底部?本文将结合公司最新的财务数据、核心业务推进、估值模型以及潜在风险,为大家拆解这家仅次于SpaceX的航天巨头的真实底牌。
行业地位与电子号火箭的商业化突破 作为全球商业航天领域的“二把手”,Rocket Lab是目前除了SpaceX之外,全球极少数具备高频次、稳定商业轨道发射能力的上市公司。公司的核心基本盘——Electron(电子号)轻型运载火箭,单次发射价格约为750万至800万美元,主要面向小型卫星及轻型载荷市场。截至近期,Electron已累计完成超过50次商业发射任务,成功率稳定在90%以上。
在财务表现方面,公司整体季度营收已稳步攀升至8000万至9000万美元区间,其中太空系统业务贡献了超过65%的收入,而火箭发射服务占比约35%。这表明Rocket Lab已成功从单纯的“火箭发射公司”转型为“综合性航天基础设施服务商”。其太空系统业务的毛利率维持在25%至30%的健康水平,为公司提供了相对稳定的现金流底座。
中子号(Neutron)火箭:打破估值天花板的胜负手 虽然Electron带来了稳定的现金流,但真正决定RKLB能否实现市值跨越式增长的核心逻辑,在于正在全力研发的中型可复用运载火箭——Neutron(中子号)。
Neutron设计运载能力为13吨,单次发射预估售价在5000万至5500万美元之间,直接对标SpaceX的猎鹰9号(Falcon 9)。一旦Neutron实现商业化首飞,Rocket Lab将正式打入大型星座部署、中轨道/高轨道载荷以及防御性太空合同等高利润市场,单次发射收入将增长约7倍。
目前,Neutron的研发正处于关键测试阶段,季度研发费用居高不下,维持在5000万至6000万美元的高位。这也直接导致公司单季度净亏损保持在4000万至5000万美元之间。目前公司资产负债表上仍持有约3.5亿至4亿美元的现金及现金等价物,按当前的烧钱速率,手头资金能够支撑约6至8个季度的研发与运营需求。
估值模型分析与财务风险预警 在估值逻辑上,由于公司仍处于研发高投入阶段,传统的市盈率(P/E)并不适用,市场主要采用市销率(P/S)和前瞻EV/EBITDA来进行定价。 当前RKLB的市销率(P/S)在8倍至11倍之间波动,相较于其历史高位已大幅挤压挤干泡沫,但相较于传统国防航空巨头(通常在1.5倍至3倍P/S)仍享有极高成长溢价。按照市场主流分析师的预测,如果Neutron能在未来12至18个月内顺利完成首飞并进入商业化推升期,公司年营收有望在2026-2027年跨越5亿至8亿美元大关。届时,前瞻P/S将快速回落至3倍至5倍的极具吸引力区间。
然而,投资者必须清醒认识到两大核心风险点: 研发延期与首飞爆炸风险:航天研发具有高度不确定性,Neutron的任何延期或首次测试失败,都将直接拖累股价下挫20%至30%。 二次股权稀释风险:若Neutron研发消耗资金超出预期,公司可能需要在公开市场通过增发股票(ATM)或发行可转换债券进行融资,从而稀释现有股东权益。
投资者可执行操作指引 针对目前的市场价位与RKLB的风险收益比,建议采用以下三条可执行的操作策略: 金字塔式分批建仓与仓位控制 航天科技股具备高贝塔属性,单日波动较大。建议将其定义为高风险卫星仓位,持仓占个人总投资组合比例严格控制在3%—5%以内。采取分批建仓策略,在估值下沿分段吸筹,切忌一次性满仓。 以Neutron关键里程碑作为加减仓信号 将操作节奏与官方节点深度绑定:重点追踪Archimedes(阿基米德)发动机的地面长时间静态点火测试、火箭第一级结构装配完成以及首飞时间表。若关键节点顺利通过,可适度加仓;若宣布重大延期,则应适当减仓规避资本效率下降风险。 设置严格的止损线与现金流跟踪机制 重点关注季度财报中的自由现金流(FCF)以及现金储备。若公司账面现金降至1.5亿美元以下且未宣布新的长周期低成本债务融资,需警惕随时可能发生的股权稀释,建议设定15%—20%的硬性止损线以规避流动性风险。
[00:00] 视频开场与核心议题引入 [01:15] Rocket Lab当前市场表现与股价走势复盘 [03:30] 电子号火箭发射业务与核心财务数据拆解 [06:40] 中子号(Neutron)火箭进展及对估值的影响 [10:10] 当前估值水平与潜在风险分析 [13:50] 总结与操作建议
[Source](https://www.bilibili.com/video/BV16CJQ6YEKv)